Eliks Małgorzata, Sowińska Anna, Gajewska Ewa
Chair and Clinic of the Developmental Neurology, Poznan University of Medical Sciences, Poznań, Poland.
Doctoral School of Poznań University of Medical Sciences, Poznań, Poland.
Front Neurol. 2022 Jul 28;13:949720. doi: 10.3389/fneur.2022.949720. eCollection 2022.
The Alberta Infant Motor Scale (AIMS) is a diagnostic tool for the assessment of the motor performance of infants from the time of birth, to the period of independent walking (0-18 months). This study aims to derive a Polish version of the AIMS through its cultural adaptation and validation. The study included 145 infants aged 0-18 months, who were divided into four further age groups: 0-3 months, 4-7 months, 8-11 months, and older than 12 months. The validation was based on an analysis of intrarater and interrater reliability values, as well as concurrent validity, using the gross motor scale of Peabody Developmental Motor Scales-2 (PDMS-2). The total Intraclass Correlation Coefficient (ICC) for intrarater reliability was 0.99 (ICC range in positions was 0.87-0.99, in subgroups was 0.91-0.99), while in particular positions, the ICC ranges were as follows: prone 0.97-0.99, supine 0.94-0.99, sitting 0.95-0.99, and standing: 0.63-0.99. The total ICC for interrater reliability was 0.99 (ICC range in positions was 0.98-0.99, in subgroups was 0.91-0.99), while in particular positions, the ICC ranges were as follows: prone 0.95-0.99, supine 0.93-0.96, sitting 0.93-0.98, standing 0.91-0.98. Only the standing position was analyzed for the subgroup of participants over 12 months old. The Spearman correlation between the Polish version of the AIMS and the gross motor scale of PDMS-2 was significant in the total population (r = 0.97, < 0.0001) and in subgroups (r = 0.79-0.85, < 0.0001). The results of our study confirm that the Polish version of the AIMS is reliable for infants aged 0-18 months and can be applied to this population for clinical and scientific purposes.
ClinicalTrials.gov ID NCT05264064, URL https://clinicaltrials.gov/ ct2/show/NCT05264064.
艾伯塔婴儿运动量表(AIMS)是一种用于评估婴儿从出生到独立行走阶段(0 - 18个月)运动表现的诊断工具。本研究旨在通过文化调适和验证得出AIMS的波兰语版本。该研究纳入了145名年龄在0 - 18个月的婴儿,他们被进一步分为四个年龄组:0 - 3个月、4 - 7个月、8 - 11个月和12个月以上。验证基于对评分者内和评分者间信度值以及同时效度的分析,使用的是皮博迪发育运动量表 - 2(PDMS - 2)的大肌肉运动量表。评分者内信度的总组内相关系数(ICC)为0.99(各体位的ICC范围为0.87 - 0.99,各亚组的ICC范围为0.91 - 0.99),而在特定体位,ICC范围如下:俯卧位0.97 - 0.99,仰卧位0.94 - 0.99,坐位0.95 - 0.99,站立位:0.63 - 0.99。评分者间信度的总ICC为0.99(各体位的ICC范围为0.98 - 0.99,各亚组的ICC范围为0.91 - 0.99),而在特定体位,ICC范围如下:俯卧位0.95 - 0.99,仰卧位0.93 - 0.96,坐位0.93 - 0.98,站立位0.91 - 0.98。仅对12个月以上的参与者亚组分析了站立位。AIMS波兰语版本与PDMS - 2大肌肉运动量表之间的斯皮尔曼相关性在总体人群中显著(r = 0.97,< 0.0001),在各亚组中也显著(r = 0.79 - 0.85,< 0.0001)。我们的研究结果证实,AIMS波兰语版本对于0 - 18个月的婴儿是可靠的,可用于该人群的临床和科研目的。
ClinicalTrials.gov标识符NCT05264064,网址https://clinicaltrials.gov/ct2/show/NCT05264064 。